Bayer AG (BAYN) — Stock analysis
EURCurrent price
35,21 €
-1,32 € (-3.61%) today
Market signals
About Bayer AG
Bayer is a German pharmaceutical and agricultural group, founded in Leverkusen in 1863 (famous for aspirin). It operates in three divisions: Pharmaceuticals (oncology — Nubeqa, Xofigo; coagulation — Xarelto; ophthalmic and cardiology), Consumer Health (OTC products like Aspirin, Bepanthen, Aleve, Claritin) and Crop Science (herbicides, fungicides, seeds after the 2018 Monsanto acquisition). The Monsanto purchase opened a massive US glyphosate litigation controversy. DAX component.
What does Bayer do?▾
Bayer makes drugs (Xarelto anticoagulant, oncology and ophthalmology drugs), OTC products (aspirin, Bepanthen) and agricultural products including herbicides (Roundup/glyphosate), fungicides and GMO seeds through its Crop Science division (formerly Monsanto).
Which exchange is Bayer listed on?▾
Bayer is listed on Xetra with ticker BAYN. It is a member of the DAX index.
Does Bayer pay dividends?▾
Yes, but the dividend was significantly reduced in 2024 to preserve cash against glyphosate litigation costs in the US. Current yield is typically 3–5%.
Analyse this stock with AI
Create a free account and get 2 credits to generate a complete analysis.
Create account · 2 free credits